FTXH ETF: First Trust Nasdaq Pharmaceuticals ETF - Price, Holdings & Analysis
First Trust Nasdaq Pharmaceuticals ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About First Trust Nasdaq Pharmaceuticals ETF
What is the current price of FTXH?
The latest FTXH price is $38.83. The 52-week range is $25.77–$39.57. FTXH has returned 43.5% over the past 52 weeks.
What is the expense ratio for FTXH?
FTXH's annual expense ratio is 0.60%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does FTXH pay dividends?
Yes, FTXH pays a 1.57% dividend yield. The last ex-dividend date was 2026-09-30. View full dividend history in the Dividends section.
What are the top holdings of FTXH?
FTXH's largest holdings are Eli Lilly and Company (7.8%), Bristol-Myers Squibb Company (7.2%), Merck & Co., Inc (7.1%) (combined weight: 22.1%). The fund holds 51 total positions. View the complete portfolio breakdown in the Holdings section.
How does FTXH compare to similar ETFs?
Compare FTXH (0.60% expense ratio, $34M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.